Intelligent Control and Automation

[1]  Raino A. E. Mäkinen,et al.  An adaptive evolutionary algorithm with intelligent mutation local searchers for designing multidrug therapies for HIV , 2007, Applied Intelligence.

[2]  Mohammad Hadi Farahi,et al.  Optimizing Chemotherapy in an HIV Model by a Pair of Optimal Control , 2007 .

[3]  L M Wahl,et al.  Costs versus benefits: best possible and best practical treatment regimens for HIV , 2007, Journal of mathematical biology.

[4]  Mostafa Rachik,et al.  Optimal control and infectiology: Application to an HIV/AIDS model , 2006, Appl. Math. Comput..

[5]  Ryan Zurakowski,et al.  A model predictive control based scheduling method for HIV therapy. , 2006, Journal of theoretical biology.

[6]  A.R. Teel,et al.  HIV treatment scheduling via robust nonlinear model predictive control , 2004, 2004 5th Asian Control Conference (IEEE Cat. No.04EX904).

[7]  Xiaohua Xia,et al.  When to initiate HIV therapy: a control theoretic approach , 2003, IEEE Transactions on Biomedical Engineering.

[8]  Chung Choo Chung,et al.  Optimal Scheduling of Drug Treatment for HIV Infection : Continuous Dose Control and Receding Horizon Control , 2003 .

[9]  Andrew R. Teel,et al.  Enhancing immune response to HIV infection using MPC-based treatment scheduling , 2003, Proceedings of the 2003 American Control Conference, 2003..

[10]  T. Yoneyama,et al.  Short and long period optimization of drug doses in the treatment of AIDS. , 2002, Anais da Academia Brasileira de Ciencias.

[11]  H. Schattler,et al.  On optimal controls for a general mathematical model for chemotherapy of HIV , 2002, Proceedings of the 2002 American Control Conference (IEEE Cat. No.CH37301).

[12]  Pini Gurfil,et al.  Optimal control of HIV infection with a continuously-mutating viral population , 2002, Proceedings of the 2002 American Control Conference (IEEE Cat. No.CH37301).

[13]  José Álvarez-Ramírez,et al.  Feedback Control of the chemotherapy of HIV , 2000, Int. J. Bifurc. Chaos.

[14]  M. Nowak,et al.  Specific therapy regimes could lead to long-term immunological control of HIV. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[15]  S. Lenhart,et al.  OPTIMIZING CHEMOTHERAPY IN AN HIV MODEL , 1998 .

[16]  J. Rubio,et al.  Existence of optimal controls for the diffusion equation , 1977 .

[17]  Winston Garira,et al.  Optimal Control of Combined Therapy in a Single Strain HIV-1 Model , 2005 .

[18]  A.R. Teel,et al.  Utilizing alternate target cells in treating HIV infection through scheduled treatment , 2004, Proceedings of the 2004 American Control Conference.